Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis

Journal of Infection

Volumn 61, Issue 4, 2010, Pages 335-342

  Maubon, Danièle ^a   Hamidfar Roy, Rebecca ^a   Courby, Stéphane ^a   Vesin, Aurélien ^b   Maurin, Max ^a   Pavese, Patricia ^a   Ravanel, Nadia ^a   Bulabois, Claude Eric ^a   Brion, Jean Paul ^a   Pelloux, Hervé ^a   Timsit, Jean François ^a,b  

^a Albert Michallon Teaching Hospital   (France)

^b INSTITUT ALBERT BONNIOT   (France)

Author keywords

Cancer; Hematological malignancies; Multiplex PCR; Sepsis diagnosis; Therapeutic impact

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BLOOD CULTURE; CLINICAL DECISION MAKING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASM; NONHUMAN; PATIENT CARE; SEPSIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; NEOPLASMS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME;

EID: 77956651447     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.07.004     Document Type: Article

References (31)

1. Vincent J.L. EPIC II: sepsis around the world. Minerva Anestesiol 2008, 74:293-296.
2. Adrie C., Francais A., Alvarez-Gonzalez A., Mounier R., Azoulay E., Zahar J.R., et al. Model for predicting short-term mortality of severe sepsis. Crit Care 2009, 13:R72.
3. Klouche M., Schroder U. Rapid methods for diagnosis of bloodstream infections. Clin Chem Lab Med 2008, 46:888-908.
4. Procop G.W. Molecular diagnostics for the detection and characterization of microbial pathogens. Clin Infect Dis 2007, 45(Suppl. 2):S99-S111.
5. Misra S., Percival R.S., Devine D.A., Duggal M.S. A pilot study to assess bacteraemia associated with tooth brushing using conventional, electric or ultrasonic toothbrushes. Eur Arch Paediatr Dent 2007, 8(Suppl. 1):42-45.
6. Lehmann L.E., Hunfeld K.P., Emrich T., Haberhausen G., Wissing H., Hoeft A., et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008, 197:313-324.
7. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317.
8. Westh H., Lisby G., Breysse F., Boddinghaus B., Chomarat M., Gant V., et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009, 15:544-551.
9. Louie R.F., Tang Z., Albertson T.E., Cohen S., Tran N.K., Kost G.J. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008, 36:1487-1492.
10. von Lilienfeld-Toal M., Lehmann L.E., Raadts A.D., Hahn-Ast C., Orlopp K.S., Marklein G., et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 2009, 47:2405-2410.
11. Dark P., Chadwick P., Warhurst G. Detecting sepsis-associated bloodstream infection acquired in intensive care using multi-pathogen real-time PCR. J Infect 2009, 59:296-298.
12. Wallet F, Nseir S, Baumann L, Herwegh S, Sendid B, Boulo M, et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect: in press. doi:10.1111/j.469-0691.2009.02940.x.
13. Mancini N., Clerici D., Diotti R., Perotti M., Ghidoli N., De Marco D., et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008, 57:601-604.
14. Varani S., Stanzani M., Paolucci M., Melchionda F., Castellani G., Nardi L., et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect 2009, 58:346-351.
15. Dierkes C., Ehrenstein B., Siebig S., Linde H.J., Reischl U., Salzberger B. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009, 9:126.
16. Casalta J.P., Gouriet F., Roux V., Thuny F., Habib G., Raoult D. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 2009, 28:569-573.
17. Adrie C., Alberti C., Chaix-Couturier C., Azoulay E., De Lassence A., Cohen Y., et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 2005, 20:46-58.
18. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008, 2008(36):296-327.
19. Sepsis. Prise en charge initiale des états septiques graves de l'adulte et de l'enfant French Multidisciplinary Group, at:, [accessed 01.08.2010]. http://www.srlf.org/Data/ModuleGestionDeContenu/application/371.pdf.
20. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for research and treatment of Cancer/Invasive fungal infections Cooperative group and the national Institute of Allergy and infectious diseases Mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008, 46:1813-1821.
21. Boye K., Hansen D.S. Sequencing of 16S rDNA of Klebsiella: taxonomic relations within the genus and to other enterobacteriaceae. Int J Med Microbiol 2003, 292:495.
22. Elting L.S., Rubenstein E.B., Rolston K.V., Bodey G.P. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997, 25:247-259.
23. Fricker-Hidalgo H., Lebeau B., Pelloux H., Grillot R. Use of the BACTEC 9240 system with mycosis-IC/F blood culture bottles for detection of fungemia. J Clin Microbiol 2004, 42:1855-1856.
24. Elting L.S., Rubenstein E.B., Rolston K., Cantor S.B., Martin C.G., Kurtin D., et al. Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care. J Clin Oncol 2000, 18:3699-3706.
25. Bretagne S., Costa J.M. Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 2005, 45:361-368.
26. Donnelly J.P. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis 2006, 42:487-489.
27. Steinmann J., Buer J., Rath P.M., Paul A., Saner F. Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast. Transpl Infect Dis 2009, 11:175-178.
28. Lehmann L.E., Alvarez J., Hunfeld K.P., Goglio A., Kost G.J., Louie R.F., et al. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 2009, 3085-3090.
29. Bloos F., Hinder F., Becker K., Sachse S., Mekontso Dessap A., Straube E., et al. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med 2009, doi:10.1007/s00134-009-1705-z.
30. Mancini N., Carletti S., Ghidoli N., Cichero P., Burioni R., Clementi M. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev 2010, 23:235-251.
31. Struelens M.J. Detection of microbial DNAemia: does it matter for sepsis management?. Intensive Care Med 2009, doi:10.1007/s00134-009-1710-2.